Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Microrna-31 Regulates T-Cell Metabolism Via HIF1α and Promotes Effector Function

Yongxia Wu, PhD MD, Mengmeng Zhang, MD, David Bastian, Mohammed Hanief Sofi, PhD MS, Steven Douglas Schutt, BS, Hee-Jin Choi, PhD, Corey Mealer, Hung D Nguyen, PhD, Linlu Tian, Xue-Zhong Yu, MD MS

Blood (2019) 134 (Supplement_1): 623.

https://doi.org/10.1182/blood-2019-131587

Published: 2019

Journal Articles

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

Giuseppe Lia, PhD, Clara Di Vito, PhD, Marta Tapparo, PhD, Stefania Bruno, Elisa Zaghi, Michela Calvi, Lucia Brunello, Jacopo Mariotti, MD, Lorenzo Comba, Luisa Giaccone, Martina Fascì, Mario Boccadoro, Andrea Evangelista, MSc, Luca Castagna, MD, Giovanni Camussi, Domenico Mavilio, Benedetto Bruno, MD

Blood (2019) 134 (Supplement_1): 598.

https://doi.org/10.1182/blood-2019-126521

Published: 2019

Journal Articles

MiR-221/222 Promote Dexamethasone Resistance of Multiple Myeloma through Inhibition of Autophagy By Targeting ATG12

Jian Xu, MD, Yan Su, MD, Aoshuang Xu, MD, Fengjuan Fan, PhD, Haifan Huang, MD, Yu Hu, MD PhD, Chunyan Sun, MD PhD

Blood (2018) 132 (Supplement 1): 4469.

https://doi.org/10.1182/blood-2018-99-111637

Published: 2018

Journal Articles

PD-L1 Expression Is Regulated By microRNAs-21 and -130 in Cutaneous T-Cell Lymphoma

Renee Estephan, BS, Sung Hee Kil, PhD, Steven T Rosen, Christiane Querfeld, MD PhD

Blood (2018) 132 (Supplement 1): 4108.

https://doi.org/10.1182/blood-2018-99-115064

Published: 2018

Journal Articles

Pirna-30473 Contributes to Tumorigenesis By Regulating RNA m6A Methylation in DLBCL

Bingzong Li, MD PhD, Huiying Han, Sha Song, Gao Fan, Nengjun Yi, Chen'ao Qian, Wenzhuo Zhuang, MD PhD

Blood (2018) 132 (Supplement 1): 2835.

https://doi.org/10.1182/blood-2018-99-114292

Published: 2018

Journal Articles

MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice

Yongxia Wu, Steven Schutt, Katelyn Paz, Mengmeng Zhang, Ryan P. Flynn, David Bastian, M. Hanief Sofi, Hung Nguyen, Min Dai, Chen Liu, Ying-Jun Chang, Bruce R. Blazar, Xue-Zhong Yu

Blood (2018) 131 (17): 1974–1986.

https://doi.org/10.1182/blood-2017-06-789321

Published: 2018

Includes: Supplemental data

Journal Articles

The Role of the Axis TGF-β1/Mir-382-5p/SOD2 in the Induction of Oxidative Stress in CD34+ Hematopoietic Stem/Progenitor Cells from Primary Myelofibrosis

Chiara Rossi, PharmD, Roberta Zini, BSc, PhD, Samantha Ruberti, BSc, PhD, Sebastiano Rontauroli, BSc, Zelia Prudente, BSc, PhD, Greta Barbieri, BSc, Elisa Bianchi, BSc, PhD, Simona Salati, BSc, PhD, Elena Genovese, BSc, Carmela Mannarelli, MSc, PhD, Paola Guglielmelli, MD PhD, Enrico Tagliafico, MDPhD, Vittorio Rosti, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, Rossella Manfredini, BSc, PhD

Blood (2017) 130 (Supplement 1): 1655.

https://doi.org/10.1182/blood.V130.Suppl_1.1655.1655

Published: 2017

Journal Articles

Circulating Micrornas (miRNA) As a Novel Liquid Biopsy and Therapeutic Platform in MYC and Non-MYC Diffuse Large B-Cell Lymphoma (DLBCL)

Afshin Beheshti, PhD, Charles Vanderburg, PhD, Ravi Dashnamoorthy, PhD, John Tyson McDonald, PhD, Amanda L Christie, BS, Kay Shigemori, Hallie Jester, Hong Zhang, PhD, David M. Weinstock, MD, Andrew M Evens, DO,MSc

Blood (2017) 130 (Supplement 1): 4005.

https://doi.org/10.1182/blood.V130.Suppl_1.4005.4005

Published: 2017

Journal Articles

Therapeutic Targeting of Microrna-214 in Cutaneous T-Cell Lymphoma

Rebecca Kohnken, DVM, Jing Wen, Kathleen McConnell, Leah Grinshpun, Ashleigh Keiter, Betina McNeil, PhD, Pierluigi Porcu, MD, Anjali Mishra, PhD

Blood (2017) 130 (Supplement 1): 4100.

https://doi.org/10.1182/blood.V130.Suppl_1.4100.4100

Published: 2017

Journal Articles

MiR-17-92 Is Required for the Pathogenicity of T and B Cells in Chronic Gvhd

Yongxia Wu, PhD, Steven D Schutt, BS, Ryan P Flynn, PhD, Mengmeng Zhang, MD, Hung D Nguyen, PhD, Bruce R. Blazar, MD, Xue-Zhong Yu, PhD

Blood (2016) 128 (22): 4535.

https://doi.org/10.1182/blood.V128.22.4535.4535

Published: 2016

Journal Articles

Vitamin D Blocks CLL Cell-Mediated MDSC Induction

Dimitrios Mougiakakos, Heiko Bruns, PhD, Martin Böttcher, Mirjeta Qorraj, Mario Fabri, Jochen Dindorf, Leonhard Busch, Regina Jitschin, Andreas Mackensen, MD

Blood (2016) 128 (22): 4355.

https://doi.org/10.1182/blood.V128.22.4355.4355

Published: 2016

Journal Articles

Microrna-138 Regulates Osteogenic Differentiation and Its Inhibition Presents a Novel Therapeutic Line to Prevent Bone Lytic Lesions in Multiple Myeloma

Shokichi Tsukamoto, MD PhD, Karma Salem, MD, Salomon Manier, MD, Michaela R. Reagan, PhD, Daisy Huynh, BS, MS, Adriana Perilla-Glen, MBA, Antonio Sacco, BS, Oksana Zavidij, PhD, Mahshid Rahmat, PhD, Satoshi Takagi, PhD, Yawara Kawano, MD PhD, Katsutoshi Kokubun, PhD, Charlotte Albæk Thrue, MSc, Andreas Petri, PhD MSc, David M. Dorfman, MD PhD, Aldo M. Roccaro, MD PhD, Marzia Capelletti, PhD MMSc, Sakari Kauppinen, PhD, Irene M. Ghobrial, MD

Blood (2016) 128 (22): 4483.

https://doi.org/10.1182/blood.V128.22.4483.4483

Published: 2016

Journal Articles

MiR-494-3p Overexpression Leads to SOCS6 Downregulation and Supports Megakaryocytopoiesis in Primary Myelofibrosis CD34+ Hematopoietic Stem/Progenitor Cells

Sebastiano Rontauroli, BSc, Ruggiero Norfo, PhD, Valentina Pennucci, PhD, Roberta Zini, PhD, Samantha Ruberti, BSc, Elisa Bianchi, PhD, Simona Salati, PhD, Zelia Prudente, PhD, Chiara Rossi, BSc, Vittorio Rosti, Paola Guglielmelli, MD PhD, Giovanni Barosi, Alessandro M. Vannucchi, MD, Enrico Tagliafico, MD PhD, Rossella Manfredini, PhDBSc

Blood (2016) 128 (22): 4272.

https://doi.org/10.1182/blood.V128.22.4272.4272

Published: 2016

Journal Articles

miR-146b antagomir–treated human Tregs acquire increased GVHD inhibitory potency

Yunjie Lu, Keli L. Hippen, Amanda L. Lemire, Jian Gu, Weizhi Wang, Xuhao Ni, Parvathi Ranganathan, Bruce L. Levine, James L. Riley, Carl H. June, Laurence A. Turka, David H. Munn, Ramiro Garzon, Ling Lu, Bruce R. Blazar

Blood (2016) 128 (10): 1424–1435.

https://doi.org/10.1182/blood-2016-05-714535

Published: 2016

Includes: Supplemental data

Journal Articles

Targeted Nanoparticles for the Delivery of Antagomir17: New Approach for the Treatment of Chronic Lymphocytic Leukemia

Sara Capolla, PhD, Riccardo Bomben, Sonia Zorzet, Ruben Spretz, Tiziana D'Agaro, Gustavo Larsen, Gabriele Pozzato, MD, Valter Gattei, MD, Luis Nunez, Paolo Macor

Blood (2015) 126 (23): 5293.

https://doi.org/10.1182/blood.V126.23.5293.5293

Published: 2015

Journal Articles

Role of the MSC-Derived Exosomal and Endogenous JAK2-SET/PP2A-Beta Catenin-Modulator Mir-300 in Leukemic Stem/Progenitor Proliferation and Survival in CML

Blood (2015) 126 (23): 53.

https://doi.org/10.1182/blood.V126.23.53.53

Published: 2015

Journal Articles

Knockdown (KD) of Mir-126 Expression Enhances Tyrosine Kinase Inhibitor (TKI)-Mediated Targeting of Chronic Myelogenous Leukemia (CML) Stem Cells

Bin Zhang, PhD, Ling Li, PhD, Ching-Cheng Chen, PhD, Anthony S. Stein, MD, Haris Ali, MD, David S. Snyder, MD, Allen Lin, Adrienne Dorrance, PhD, Piotr Swiderski, PhD, Ravi Bhatia, MD, Danilo Perrotti, MD PhD, Stephen J. Forman, MD, Ya-Huei Kuo, PhD, Marcin Kortylewski, PhD, Guido Marcucci, MD

Blood (2015) 126 (23): 51.

https://doi.org/10.1182/blood.V126.23.51.51

Published: 2015

Journal Articles

MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice

Yongxia Wu, Jessica Heinrichs, David Bastian, Jianing Fu, Hung Nguyen, Steven Schutt, Yuejun Liu, Junfei Jin, Chen Liu, Qi-Jing Li, Changqing Xia, Xue-Zhong Yu

Blood (2015) 126 (11): 1314–1323.

https://doi.org/10.1182/blood-2015-02-627356

Published: 2015

Includes: Supplemental data

Journal Articles

MicroRNA-155–deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation

Sophia Chen, Benjamin A. H. Smith, Joseena Iype, Alessandro Prestipino, Dietmar Pfeifer, Sebastian Grundmann, Annette Schmitt-Graeff, Marco Idzko, Yvonne Beck, Gabriele Prinz, Jürgen Finke, Justus Duyster, Robert Zeiser

Blood (2015) 126 (1): 103–112.

https://doi.org/10.1182/blood-2014-12-617258

Published: 2015

Includes: Supplemental data

Journal Articles

MiR-29b Counteracts Aberrant HDAC4 Expression and Enhances Vorinostat Activity in Multiple Myeloma

Nicola Amodio, PhD, Marzia Leotta, MD, Anna Maria Gullà, MD, Lavinia Raimondi, PhD, Eugenio Morelli, MD, Maria Angelica Stamato, Teresa Calimeri, MD PhD, Maria Teresa Di Martino, PhD, Marco Rossi, MD, Emanuela Leone, PhD, Antonino Neri, Pierosandro Tagliaferri, MD, Pierfrancesco Tassone, MD

Blood (2014) 124 (21): 2060.

https://doi.org/10.1182/blood.V124.21.2060.2060

Published: 2014

NARROW

Microrna-31 Regulates T-Cell Metabolism Via HIF1α and Promotes Effector Function

Plasmatic Extracellular Vesicles in Acute Graft-Versus-Host Disease after Haplo-Identical Allografting with Post-Transplant Cyclophosphamide

MiR-221/222 Promote Dexamethasone Resistance of Multiple Myeloma through Inhibition of Autophagy By Targeting ATG12

PD-L1 Expression Is Regulated By microRNAs-21 and -130 in Cutaneous T-Cell Lymphoma

Pirna-30473 Contributes to Tumorigenesis By Regulating RNA m6A Methylation in DLBCL

MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice

The Role of the Axis TGF-β1/Mir-382-5p/SOD2 in the Induction of Oxidative Stress in CD34+ Hematopoietic Stem/Progenitor Cells from Primary Myelofibrosis

Circulating Micrornas (miRNA) As a Novel Liquid Biopsy and Therapeutic Platform in MYC and Non-MYC Diffuse Large B-Cell Lymphoma (DLBCL)

Therapeutic Targeting of Microrna-214 in Cutaneous T-Cell Lymphoma

MiR-17-92 Is Required for the Pathogenicity of T and B Cells in Chronic Gvhd

Vitamin D Blocks CLL Cell-Mediated MDSC Induction

Microrna-138 Regulates Osteogenic Differentiation and Its Inhibition Presents a Novel Therapeutic Line to Prevent Bone Lytic Lesions in Multiple Myeloma

MiR-494-3p Overexpression Leads to SOCS6 Downregulation and Supports Megakaryocytopoiesis in Primary Myelofibrosis CD34+ Hematopoietic Stem/Progenitor Cells

miR-146b antagomir–treated human Tregs acquire increased GVHD inhibitory potency

Targeted Nanoparticles for the Delivery of Antagomir17: New Approach for the Treatment of Chronic Lymphocytic Leukemia

Role of the MSC-Derived Exosomal and Endogenous JAK2-SET/PP2A-Beta Catenin-Modulator Mir-300 in Leukemic Stem/Progenitor Proliferation and Survival in CML

Knockdown (KD) of Mir-126 Expression Enhances Tyrosine Kinase Inhibitor (TKI)-Mediated Targeting of Chronic Myelogenous Leukemia (CML) Stem Cells

MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice

MicroRNA-155–deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation

MiR-29b Counteracts Aberrant HDAC4 Expression and Enhances Vorinostat Activity in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only